Sweetening the pot: adding glycosylation to the biomarker discovery equation - Wikidata - wikimedia - TriplyDB

Sweetening the pot: adding glycosylation to the biomarker discovery equation

Sweetening the pot: adding glycosylation to the biomarker discovery equation

http://www.wikidata.org/entity/Q33768460

about

Mass Spectrometry-Based N-Glycomics of Colorectal Cancer Biomarkers of postoperative delirium and cognitive dysfunction Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass Spectrometry Regulation of the metastatic cell phenotype by sialylated glycans Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Ubiquitous Importance of Protein Glycosylation.Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptides Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometry Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Infection, immunoregulation, and cancer.Sialylated Lewis x antigen bearing glycoproteins in human plasma Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma BFMP: a method for discretizing and visualizing pyranose conformations.Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer.The sweet and sour of serological glycoprotein tumor biomarker quantification.Glycomic profiling of tissue sections by LC-MS Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS.Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers.Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer.N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry Preparation of hydrazine functionalized polymer brushes hybrid magnetic nanoparticles for highly specific enrichment of glycopeptides.Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.Aberrant glycosylation associated with enzymes as cancer biomarkers.Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma.A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma Noninvasive imaging of sialyltransferase activity in living cells by chemoselective recognition.Absolute quantitation of glycosylation site occupancy using isotopically labeled standards and LC-MS.Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.The scientific exploration of saliva in the post-proteomic era: from database back to basic function.Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer.Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study Identification of glycoproteins containing specific glycans using a lectin-chemical method.

P2860

Q26774414-CFB4DAD1-4464-427C-AF49-6A8C7DC82149 Q26830796-42FC5070-E39D-48DB-AFA3-8B2137928D9B Q27024150-1AEF1F84-5246-498E-A247-E4FA967CD9BE Q27027559-F3C6E4AC-3F31-44ED-BE1E-B1A187D0D982 Q30382105-5BB298B5-5014-4ABC-BB6C-2723265BA26F Q30394129-284AB09E-A732-45EA-9DD9-4EC314139A0F Q30600084-C412EC7D-F20D-46C1-94AB-90A2F5DEA25E Q31121236-610CB402-545D-4B79-8F4E-25C35E9AC408 Q33655094-6116C731-95C0-4848-B9F1-8D4DDEF7721B Q33669587-281F7635-0163-4C61-83E6-845934409EB7 Q33759186-5BDDA63A-7067-47D3-A81E-301722D6D5BD Q33802722-8D693410-7D34-4485-BAA6-4C29C3959223 Q33807752-077AA621-24EC-417B-A1D5-79B2FCD3DDA8 Q34058682-FAA9CF5F-F6B0-4BD5-B96B-3BAFA1CAF7C1 Q34166653-87ED41E1-4BA3-45F3-97EE-B33115D065A4 Q34289582-355CE535-4DB1-48CC-96E4-A019E6E8F523 Q34332296-8FD9009F-EC57-4F4A-BACC-5799A913534E Q34408270-F37A809F-61C8-465F-A84C-A18E4587C888 Q34541208-88D036E8-16F6-42D0-BA7F-574BE597AC9E Q34577155-6535C172-33A3-41F5-9B8D-12CA5EFED98A Q34580285-C5C7B5F5-B15F-487C-AEB4-4B1029682766 Q34601075-CBCEF78E-B9F3-4624-8530-D4F6136873A1 Q34680098-4FBBA6BD-E828-4E2A-B6B8-DE61495B331A Q34785893-66C49F64-2CA3-48C0-9912-EAAAF1D0313C Q34900010-04604908-5D67-4384-B5F3-3D03624FF541 Q35026909-09C6F4AF-6763-408A-8A78-49D4332AE681 Q35064045-82AD22F7-09BF-4AAF-B1F7-A4177F067F34 Q35116711-3055CFF5-F446-4CB2-9D34-451AD9601C24 Q35140429-EEDE993D-D1FA-4AEC-80F4-E0AD5164B6B9 Q35206309-520EE2D2-74B9-4A05-A370-55E2E09B44BA Q35356642-39F82183-587F-42CB-84EE-D3F1805D54C1 Q35499086-E441D80E-361B-4EA1-B2E3-79ACE6DFC2E1 Q35610651-88DD42D8-01DA-449A-A6F9-4A0EE49A53F6 Q35686882-302E2F9A-5F04-4FCB-BD4C-6012ED2473C1 Q35690973-B0C8C110-9790-4C68-884F-D981C4D7596D Q35692128-D3B2E094-6AE3-4533-BE4D-FB73BE15E7AC Q35786242-B428FDB8-CD76-4E61-8940-001B5091D33C Q35818634-3AD7B03C-D809-4BC9-8582-F587C75D1678 Q35821983-2F872481-F815-456B-82DC-0361AB3E653A Q35833266-8DE66CB5-C0C5-45D6-9164-51FE8D57F57A

P2860

Sweetening the pot: adding glycosylation to the biomarker discovery equation

http://www.wikidata.org/entity/Q33768460

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@ast

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@en

type

label

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@ast

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@en

prefLabel

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@ast

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@en

P1433

Q33768460-FC77AAAF-3976-4C30-8677-2C70EE8EBC6B

P1476

Q33768460-CB2298AA-8B78-48FB-9182-93C0262524EC

P2093

Q33768460-012E1FCB-7DD9-490D-A8D2-476B3A9A801C

Q33768460-14841B8E-0CE2-4A0E-9848-D10974C963A5

Q33768460-19623522-1C2F-4FC5-AAD7-28DFD2F34C79

Q33768460-7E98171E-2313-45C6-803C-1FF0AFD96962

Q33768460-9E02AE60-9935-415F-AB56-CABA03D49844

Q33768460-B4FA91E7-32CC-43D8-84F8-16F83A7CBB55

Q33768460-C684476C-E6CD-4F02-80EE-3796C0B53E80

Q33768460-C8C00D9E-E218-49F5-AB7E-44F8797CE58F

Q33768460-DD80A706-88AF-4642-8CD0-6543E8BA9190

P2860

Q33768460-008CE608-C6BA-404E-86FF-4D3B2373B8B3

Q33768460-08C21875-34FB-4839-A147-26C284603D59

Q33768460-0C360C11-3B52-4361-9689-B814E68317D7

Q33768460-10115DF0-4A02-44BB-B2D8-63F70C9AE8DB

Q33768460-1947DAE8-757E-4194-BEBE-1FD2CB359BFC

Q33768460-1F13ABDD-6607-4936-8D6C-B2CCA6558935

Q33768460-1F941E87-3A59-4CB2-8894-2C660974B457

Q33768460-22E17F2C-260A-4779-A0B7-6668E3F6BB4C

Q33768460-23B3210C-EB14-4C6F-B4A2-C2EF9BA90433

Q33768460-29B15450-7145-4021-8D78-F412C96248E6

P304

Q33768460-3784B37A-3524-44B0-AA23-41A1B494D9A8

P31

Q33768460-F6247586-6C84-4E80-9780-12F4D8383A02

P356

Q33768460-78BC2A00-53AD-4146-A6C5-EB0E34097E50

P407

Q33768460-532FD74E-B79B-4F88-A4F9-9BC6743CF95A

P433

Q33768460-15612C1C-9675-4933-A043-1C1A50625310

P478

Q33768460-EA9172DC-1179-4818-AC38-ED32942D7A13

P577

Q33768460-1BB90924-C640-4E9B-A2F8-F48B347FE3D0

P5875

Q33768460-B09CA8B6-8124-4958-8E0E-BF00A6F9DFEB

P698

Q33768460-808692BC-EE64-4F21-B518-FCEF5FF06D42

P921

Q33768460-B2F76F3B-020C-4629-8B91-B3D24BEEA017

Q33768460-DC56416C-C0B3-4C9E-B9B8-9345B7B3E525

P932

Q33768460-6869907C-5F9E-41FD-98C5-1FBC6E631616

P356

CLINCHEM.2009.136333

P1433

Clinical Chemistry

P1476

Sweetening the pot: adding glycosylation to the biomarker discovery equation

@en

P2093

Akraporn Prakobphol

http://www.w3.org/2001/XMLSchema#string

Bensheng Li

http://www.w3.org/2001/XMLSchema#string

Bradford W Gibson

http://www.w3.org/2001/XMLSchema#string

Eric Johansen

http://www.w3.org/2001/XMLSchema#string

Fred E Regnier

http://www.w3.org/2001/XMLSchema#string

N Leigh Anderson

http://www.w3.org/2001/XMLSchema#string

Penelope M Drake

http://www.w3.org/2001/XMLSchema#string

Susan J Fisher

http://www.w3.org/2001/XMLSchema#string

Wonryeon Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow

The role of CA125 in clinical practice

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

Structural determination of N-linked glycans by matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry.

Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.

P304

223-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2009.136333

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40446616

http://www.w3.org/2001/XMLSchema#string

P698

19959616

http://www.w3.org/2001/XMLSchema#string

P921

P932

2849286

http://www.w3.org/2001/XMLSchema#string